Navigation Links
Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
Date:1/3/2008

ASHBURN, Va., Jan. 2 /PRNewswire/ -- Innocoll, Inc., a privately-held specialty pharmaceutical company, announced that the first of two phase 3 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the prevention of surgical site infections, has commenced dosing.

GENTAMICIN SURGICAL IMPLANT is a fully biodegradable, leave-behind surgical implant impregnated with the broad spectrum aminoglycoside antibiotic, gentamicin. It is designed to provide a high concentration of gentamicin (which has a concentration-dependent mechanism of action) directly to the target tissue for localized action, while maintaining low systemic levels well below the toxicity threshold. The product was developed using Innocoll's proprietary collagen-based drug delivery technology, CollaRx, and (outside of the US) is indicated as an adjunct to systemic antibiotic therapy for the treatment of localized, deep tissue infections and the prevention of surgical site infections in both hard and soft tissues. GENTAMICIN SURGICAL IMPLANT is already approved in 49 countries spanning Europe, Latin America, Middle East, Africa and Asia and there are more than 60 prospective clinical trials and published case reports totalling over 7,500 patients documenting its safety and efficacy over a broad range of orthopaedic, colorectal, cardiothoracic, vascular, and neurosurgical procedures.

Following a pre-IND meeting with the FDA earlier this year, Innocoll will conduct two multi-centered phase 3 clinical trials in the US to support the planned New Drug Application (NDA); the first in cardiac surgery patients at higher risk of surgical site infection and the second, expected to start later this month, in patients undergoing open colorectal surgery, which is considered to be the category most prone to surgical site infection. Innocoll has appointed Duke University's Duke Clinical Research Institute (DCRI) as
'/>"/>

SOURCE Innocoll, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
2. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... N.J. , July 30, 2014 Stryker brand ambassadors ... this week at the 3M Championship Champions Tour event near ... Cities, in Blaine . Stryker is the official ... Starting Friday, August 1 st through Sunday, ... Stryker Mobility Zone; an on-site joint health destination located in the ...
(Date:7/30/2014)... 2014 Silicon Valley Bank, the bank of ... that examines the merger, acquisition and IPO activity ... to the annual report based on 2013 data, venture ... SVB started tracking the data in 2005. ... solid healthcare M&A activity over the last few years, ...
(Date:7/30/2014)... NEW YORK , July 30, 2014 /PRNewswire/ ... new products for oncology supportive care, announced that its ... been featured in an article on OncLive.com titled, "Study ... and Neck Cancers."  Dr. Steve Sonis , a ... growing demand seen in the oncology community for evidence-based ...
Breaking Medicine Technology:Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 3Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 4Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 5Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3
... TITUSVILLE, N.J., July 24 Ortho-McNeil Neurologics, a,division ... Food and Drug Administration (FDA) has granted pediatric,exclusivity ... to a Written Request by the FDA to ... 1 to 24 months with partial onset seizures., ...
... Oncology Patient Accrual, DENVER, July 24 ... has contracted with five leading pharmaceutical,companies to ... their,clinical trials using the Just-in-Time (JIT) enrollment ... indications: follicular Non-Hodgkin,s,Lymphoma, Metastatic Breast Cancer, Metastatic ...
Cached Medicine Technology:FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2
(Date:7/30/2014)... adults is being financially exploited often by their ... affects poor and black people. It merits the scrutiny ... cares about the dignity and well-being of older Americans, ... in the US. She led one of the largest ... which appear in the Journal of General Internal ...
(Date:7/30/2014)... within a large teaching hospital in Ireland has shown than ... in place to minimise the risk of entrapment. The report, ... therefore emphasises the need for careful selection of patients for ... need for monitoring and maintenance of hospital bed systems. , ... falling from bed. However, although the risk for any individual ...
(Date:7/30/2014)... July 30, 2014 The report entitled ... an insight into the market dynamics and changing trends ... the actual and forecasted market sizing of the global ... fuelling the demand of the same. It further captures ... major players in the market. Further, the report discusses ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Los ... comprehensive cosmetic dental treatments that can help patients create ... Dental. Healthy teeth and gums form the foundation of ... smile. While minor chips, misshapen teeth or stains may ... from a smile’s appearance. The right cosmetic treatments can ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Building ENT ... throat, allergy, and audiology practice in Westchester County takes ... state-of-the-art technology, a superb underlying corporate structure and protocols, ... It also takes a leading Chief Financial Officer to ... Journal (WCBJ), that’s exactly what it possesses. In fact, ...
Breaking Medicine News(10 mins):Health News:Older adults are at risk of financial abuse 2Health News:High frequency of potential entrapment gaps in hospital beds 2Health News:Global Pulse Oximetry Market 2018 Opportunities and Trends Now Available at MarketReportsOnline.com 2Health News:Global Pulse Oximetry Market 2018 Opportunities and Trends Now Available at MarketReportsOnline.com 3Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Comprehensive Cosmetic Dental Treatments 2Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Comprehensive Cosmetic Dental Treatments 3Health News:The Leading Ear, Nose, and Throat Practice in Westchester County Has One of the Leading CFO’s in Westchester County! 2Health News:The Leading Ear, Nose, and Throat Practice in Westchester County Has One of the Leading CFO’s in Westchester County! 3
... Bethesda, MD -- Eliminating polio everywhere will require global ... poor countries to vaccinate with inactivated polio vaccine (IPV), ... Health Affairs thematic issue on global health. ... been achieved by 2000, but the effort to fight ...
... week in the open access journal PLoS Medicine ... in Australia, encouraging the use of pedometers simple step ... and promoting physical activity through mass media campaigns are ... the health benefits they result in. Considered as a package, ...
... , COLUMBUS, Ohio, July 13 With ... which provide around-the-clock care to 80,000 frail elderly and disabled ... meeting increased demand for quality, around-the-clock care with $184 million ... As a result, skilled nursing facilities will have to reduce ...
... 13 The Department of Defense has selected United Health Military ... the South Region. This decision comes at the completion of ... , , (Logo: ... After a Wednesday debriefing from the TRICARE Management Activity, TriServ ...
... modeling of radiation risk suggests that widespread screening for ... tomography scans would lead to an estimated 42 additional ... per 100,000 women, according to a report in the ... , one of the JAMA/Archives journals. Coronary artery ...
... 31 to July 14, a six-man international crew called ... composed of four Russians and two Europeans, simulated a ... scenarios, including emergency situations and 20-minute communications delays. ... teams with experiments evaluating solutions to conditions that impact ...
Cached Medicine News:Health News:Eliminating polio requires global, coordinated effort -- Health Affairs article highlights risks, rewards of eradication 2Health News:Eliminating polio requires global, coordinated effort -- Health Affairs article highlights risks, rewards of eradication 3Health News:Eliminating polio requires global, coordinated effort -- Health Affairs article highlights risks, rewards of eradication 4Health News:Eliminating polio requires global, coordinated effort -- Health Affairs article highlights risks, rewards of eradication 5Health News:What are the most effective ways of promoting physical exercise in adults? 2Health News:What are the most effective ways of promoting physical exercise in adults? 3Health News:State Budget Will Hurt Care in Skilled Nursing Facilities 2Health News:Study estimates radiation dose, cancer risk from coronary artery calcium screening 2Health News:Study estimates radiation dose, cancer risk from coronary artery calcium screening 3Health News:105-day Mars simulation: US studies focus on improving work performance 2Health News:105-day Mars simulation: US studies focus on improving work performance 3Health News:105-day Mars simulation: US studies focus on improving work performance 4
The NOW® Flu B test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results an...
... Genetic Analyzer is an automated single-capillary genetic ... sequencing and fragment analysis applications. An affordable, ... who incorporate genetic analysis into their work., ... alternative to gel-based DNA analysis for any ...
... surgery represents one of the most technically ... Pelvic Plating System offers the highly specialized ... addressing fractures of the pelvis and acetabulum. ... as a premiere pelvic surgeon, is the ...
... The ACE Titanium Small Fragment System has ... surgeon with superior implants and user-friendly instrumentation. ... cannulated screws, and fracture instrumentation is designed ... armamentarium to utilize current and classic techniques ...
Medicine Products: